Wall St Price Targets

AKBM Price Forecast
Based on 3 analysts

-4% Downside
from kr122 today

Aker Biomarine ASA (AKBM)’s 12-month stock price forecast through October 2027 has a consensus target of kr117.3, implying 4% downside. The forecast is based on price targets from 3 Wall Street analysts.

AKBM Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for AKBM yet.

Aker Biomarine ASA Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is AKBM's stock price target?
Price Target
117.3 NOK

According to Wall Street analysts, the average 1-year price target for AKBM is 117.3 NOK with a low forecast of 116.15 NOK and a high forecast of 120.75 NOK.

What is the Revenue forecast for Aker Biomarine ASA?
Projected CAGR
11%

Over the last 9 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 11%.

What is the Gross Profit forecast for Aker Biomarine ASA?
Projected CAGR
15%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 15%.

What is the Operating Income forecast for Aker Biomarine ASA?
Projected CAGR
70%

Over the last 9 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 3 years is 70%.

Back to Top